Form D — Oncotelic Therapeutics, Inc.
0001493152-26-034225 · filed Jul 22, 2026
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $711,840
- Total sold
- $711,840
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Oncotelic Therapeutics, Inc.
- CIK
- 908259
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 29397 AGOURA ROAD
AGOURA HILLS, CA 91301 - Phone
- 650-635-7000
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
VUONG TRIEU · Executive OfficerAGOURA HILLS, CA Find on LinkedIn ↗
-
STEVEN KING · DirectorAGOURA HILLS, CA Find on LinkedIn ↗
-
ANTHONY MAIDA · Executive OfficerAGOURA HILLS, CA Find on LinkedIn ↗
-
SHAH AMIT · Executive OfficerAGOURA HILLS, CA Find on LinkedIn ↗
-
SEYMOUR FEIN · Executive OfficerAGOURA HILLS, CA Find on LinkedIn ↗
-
SARAN SAUND · Executive OfficerAGOURA HILLS, CA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗